Related Experiment Video
Updated: Apr 28, 2026

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
2.1K
Renal metastasis from thyroid carcinoma: a case report
Summary
Renal metastasis of thyroid carcinoma is rare, presenting as a unilateral kidney mass. Immunohistochemistry is crucial for diagnosis, distinguishing it from primary kidney cancer.
Area of Science:
- Oncology
- Nephrology
- Endocrinology
Background:
- Renal metastases from thyroid carcinoma are exceptionally rare, accounting for approximately 3% of all kidney metastases.
- The English literature documents only 23 reported cases of renal thyroid carcinoma metastasis.
Observation:
- A 77-year-old male presented with gross hematuria.
- CT imaging revealed a 5 x 3 cm mass in the right kidney, located cortico-sinusally.
- Gross and microscopic examination showed a lobulated mass with papillary and follicular proliferation, containing colloid-like material.
Findings:
- Immunohistochemical staining for thyroglobulin and thyroid transcription factor-1 confirmed the thyroid origin of the renal mass.
- The findings supported the diagnosis of a renal metastasis of thyroid carcinoma.
Implications:
- Renal metastasis of thyroid carcinoma should be considered in the differential diagnosis of unilateral renal masses, even without a history of thyroid surgery.
- Distinguishing metastatic thyroid carcinoma from primary renal tumors like thyroid-like follicular carcinoma is critical.
- Immunohistochemistry plays a vital role in accurate diagnosis and subsequent patient management.
Related Concept Videos
Hyperthyroidism I: Introduction
29
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
29
Graves Disease II: Pathophysiology
26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26
Hyperthyroidism II: Pathophysiology
26
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
26
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K

